Bethany Samuelson Bannow Welcomed to Department of Hematology and Medical Oncology at the Cancer Institute Cleveland Clinic
Jame Abraham, Chairman and Professor, Department of Hematology and Medical Oncology at Cleveland Clinic, shared on LinkedIn:
”We are thrilled to welcome Dr, Bethany Samuelson Bannow as the Program Leader of Classical Hematology in the Department of Hematology and Medical Oncology at the Cancer Institute Cleveland Clinic
Dr. Samuelson Bannow earned her medical degree from Oregon Health and Science University completed her residency at the University of California, San Francisco, and her fellowship at the University of Washington.
She has served as an Acting Instructor at the University of Washington and later as Assistant Professor and Associate Professor in Hematology and Oncology at OHSU.
A hematologist, scientist, and educator, Dr. Samuelson Bannow is passionate about advancing the care of patients with bleeding and clotting disorders.
She has led and participated in multiple clinical trials focused on hemophilia, von Willebrand disease, and other bleeding disorders, and her research centers on blood clotting regulation and women’s health in hematology.
She is also actively engaged in professional leadership, serving as Associate Editor of ASH Clinical News, Co-Chair of the Thrombosis Subcommittee of the Foundation for Women and Girls
With Blood Disorders, and on committees for the Hemostasis and Thrombosis Research Society and the American Board of Internal Medicine American Society of Hematology.”
Stay updated with Hemostasis Today.
-
Nov 27, 2025, 16:00Nathan Connell on WFH AI Summaries from the Global Forum
-
Nov 27, 2025, 15:49Piotr Czempik: Rethinking Coagulation in Acute Liver Dysfunction
-
Nov 27, 2025, 15:35Overwhelmed? A Leader’s Guide from Mark Crowther to Getting Back on Track
-
Nov 27, 2025, 15:10Wolfgang Miesbach’s Top 10 Picks for TTP and Thrombosis from ASH 2025
-
Nov 27, 2025, 14:24ICCBBA’s Executive Director Eoin McGrath Chairs a Dynamic Session on AI, Innovation and Informatics in Transfusion Medicine
-
Nov 27, 2025, 13:26Wolfgang Miesbach’s Top 10 Picks for Bleeding Disorders from ASH 2025
-
Nov 27, 2025, 11:19Priya Prasad Presents a Case of Severe Hypotensive Transfusion Reaction
-
Nov 27, 2025, 04:07Eugene Tang Presents Highlights from UK Stroke Forum 2025
-
Nov 27, 2025, 03:47Michael Makris: I Believe the Time Has Come to Consider Emicizumab Up Front in Persons with Acquired Hemophilia